Abbott Labs First-Quarter Results Top Estimates, Earnings Outlook ShortInvestors Business Daily • 04/20/22
Abbott predicts fewer sales of COVID-19 tests in 2022 but says the business of at-home tests isn't going awayMarket Watch • 04/20/22
Abbott Laboratories (ABT) CEO Robert Ford on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/20/22
Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart RhythmsPRNewsWire • 04/04/22
Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply ChainPRNewsWire • 03/30/22
Investing Club: We don't need two stocks tied to Covid diagnostics, so we exited one of themCNBC • 03/28/22
Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use InsulinPRNewsWire • 03/24/22